BioSig Technologies, Inc.
BSGM
$0.60
-$0.136-18.48%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 48.98% | 43.53% | 4.96% | -7.35% | -4.22% |
| Total Depreciation and Amortization | -13.36% | -11.24% | -3.96% | -1.80% | 12.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.70% | -8.69% | 115.92% | 144.37% | 95.75% |
| Change in Net Operating Assets | -612.42% | -225.26% | 2,728.00% | 65.73% | 397.13% |
| Cash from Operations | 60.91% | 51.21% | 39.38% | 20.23% | 20.74% |
| Capital Expenditure | 98.33% | 72.17% | 10.76% | -10.71% | 5.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.33% | 72.17% | 10.76% | -10.71% | 5.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.22% | -33.67% | -32.56% | 45.34% | 134.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -74.41% | -- | -- | -- |
| Cash from Financing | -59.09% | -34.53% | -15.32% | 63.96% | 163.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.38% | 122.27% | 86.27% | 98.52% | 97.01% |
